What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Respiratory

PUBLISHER: 360iResearch | PRODUCT CODE: 1317686

PUBLISHER: 360iResearch | PRODUCT CODE: 1317686

Cough Suppressant Drugs Market by Disease Type, Drug Type, Age Group, Dosage Form, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

PUBLISHED: June 12, 2023

PAGES: 191 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The Global Cough Suppressant Drugs Market is forecasted to grow significantly, with a projected USD 1,982.79 million in 2023 at a CAGR of 4.61% and expected to reach a staggering USD 2,722.85 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cough Suppressant Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cough Suppressant Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Disease Type, market is studied across Dry Cough and Wet Cough. The Wet Cough is projected to witness significant market share during forecast period.

Based on Drug Type, market is studied across Benzonatate, Butamirate, Codeine, Dextromethorphan, Noscapine, and Pholcodine. The Dextromethorphan is projected to witness significant market share during forecast period.

Based on Age Group, market is studied across Adult and Pediatric. The Adult is projected to witness significant market share during forecast period.

Based on Dosage Form, market is studied across Syrup and Tablet. The Syrup is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital, Online Pharmacy, and Retail Drug Store. The Hospital is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cough Suppressant Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cough Suppressant Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cough Suppressant Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cough Suppressant Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Cough Suppressant Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Cough Suppressant Drugs Market?

6. What is the market share of the leading vendors in the Global Cough Suppressant Drugs Market?

7. What modes and strategic moves are considered suitable for entering the Global Cough Suppressant Drugs Market?

Product Code: MRR-4311CE1A33E5

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Cough Suppressant Drugs Market, by Disease Type, 2022 vs 2030
4.3. Cough Suppressant Drugs Market, by Drug Type, 2022 vs 2030
4.4. Cough Suppressant Drugs Market, by Age Group, 2022 vs 2030
4.5. Cough Suppressant Drugs Market, by Dosage Form, 2022 vs 2030
4.6. Cough Suppressant Drugs Market, by Distribution Channel, 2022 vs 2030
4.7. Cough Suppressant Drugs Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increase in the cases of chronic lung disorders
  - 5.1.1.2. Surge in the number of smokers globally
  - 5.1.1.3. Emergence in vulnerable indoor as well as outdoor allergens
- 5.1.2. Restraints
  - 5.1.2.1. Huge cost associated with treatment and shortage of skilled labor
- 5.1.3. Opportunities
  - 5.1.3.1. Development of novel therapies and drugs
  - 5.1.3.2. Government initiatives for advanced healthcare infrastructures
- 5.1.4. Challenges
  - 5.1.4.1. Side impacts of cough suppressant drugs
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Cough Suppressant Drugs Market, by Disease Type

6.1. Introduction
6.2. Dry Cough
6.3. Wet Cough

7. Cough Suppressant Drugs Market, by Drug Type

7.1. Introduction
7.2. Benzonatate
7.3. Butamirate
7.4. Codeine
7.5. Dextromethorphan
7.6. Noscapine
7.7. Pholcodine

8. Cough Suppressant Drugs Market, by Age Group

8.1. Introduction
8.2. Adult
8.3. Pediatric

9. Cough Suppressant Drugs Market, by Dosage Form

9.1. Introduction
9.2. Syrup
9.3. Tablet

10. Cough Suppressant Drugs Market, by Distribution Channel

10.1. Introduction
10.2. Hospital
10.3. Online Pharmacy
10.4. Retail Drug Store

11. Americas Cough Suppressant Drugs Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Cough Suppressant Drugs Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Cough Suppressant Drugs Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

Product Code: MRR-4311CE1A33E5

LIST OF FIGURES

FIGURE 1. COUGH SUPPRESSANT DRUGS MARKET RESEARCH PROCESS
FIGURE 2. COUGH SUPPRESSANT DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2022 VS 2030 (%)
FIGURE 5. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
FIGURE 6. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2022 VS 2030 (%)
FIGURE 7. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2022 VS 2030 (%)
FIGURE 8. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 9. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 10. COUGH SUPPRESSANT DRUGS MARKET DYNAMICS
FIGURE 11. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. COUGH SUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 21. COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. COUGH SUPPRESSANT DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 5. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 8. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 15. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 18. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 43. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 44. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 48. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 49. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 68. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 69. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 70. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 71. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 74. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 84. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 85. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 86. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 115. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 116. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 130. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 132. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 135. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 136. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 137. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 140. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 142. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 146. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 147. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 151. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 152. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 161. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 162. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 175. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 176. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 177. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 179. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 180. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 181. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 182. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 185. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 186. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 187. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 206. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 207. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 220. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 222. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. COUGH SUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 234. COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 235. COUGH SUPPRESSANT DRUGS MARKET LICENSE & PRICING